Testing effectiveness (Phase 2)Study completedNCT03638141
What this trial is testing
CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab
Who this might be right for
Intermediate Stage of Hepatocellular CarcinomaHepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21